HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R Gregory Bociek Selected Research
R Gregory Bociek Research Topics
Disease
6
Hodgkin Disease (Hodgkin's Disease)
01/2020 - 12/2011
5
Lymphoma (Lymphomas)
01/2023 - 02/2005
4
Neoplasms (Cancer)
04/2024 - 12/2007
4
Hematologic Neoplasms (Hematological Malignancy)
11/2016 - 09/2003
3
Burkitt Lymphoma (Burkitt's Lymphoma)
11/2018 - 06/2005
3
Thrombocytopenia (Thrombopenia)
11/2016 - 03/2007
3
Tumor Lysis Syndrome
03/2015 - 03/2007
3
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2012 - 10/2008
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 06/2011
2
Leukemia
03/2015 - 07/2014
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2007 - 03/2007
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2022
1
Pain (Aches)
01/2022
1
Pericarditis
01/2016
1
Pericardial Effusion
01/2016
1
B-Cell Lymphoma (Lymphoma, B Cell)
11/2015
1
Hypersensitivity (Allergy)
10/2015
1
Anaphylaxis (Anaphylactic Shock)
10/2015
1
Hypotension (Low Blood Pressure)
03/2015
1
Primary Myelofibrosis (Myelosclerosis)
03/2015
1
Anemia
03/2015
1
Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2015
1
Essential Thrombocythemia
03/2015
1
Disseminated Intravascular Coagulation
03/2015
1
Leukocytosis (Pleocytosis)
03/2015
1
Fever (Fevers)
03/2015
1
Philadelphia Chromosome
07/2014
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2014
1
Disease Resistance
09/2007
1
Disease Progression
09/2007
1
Second Primary Neoplasms (Neoplasms, Second)
03/2007
1
Opportunistic Infections (Opportunistic Infection)
03/2007
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2005
Drug/Important Bio-Agent (IBA)
3
Brentuximab Vedotin
IBA
01/2020 - 10/2015
3
Rituximab (Mabthera)
FDA Link
11/2015 - 10/2008
2
Bendamustine Hydrochloride
FDA Link
01/2020 - 01/2018
2
Histone Deacetylase Inhibitors
IBA
01/2016 - 12/2011
2
Monoclonal Antibodies
IBA
10/2015 - 02/2008
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2008 - 03/2007
1
ibrutinib
IBA
04/2024
1
Lenalidomide (CC 5013)
FDA Link
01/2023
1
carfilzomib
IBA
02/2022
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
11/2016
1
Heparin (Liquaemin)
FDA Link
Generic
11/2016
1
Warfarin (Coumadin)
FDA Link
Generic
11/2016
1
entinostat (MS 275)
IBA
01/2016
1
Antibodies
IBA
01/2016
1
Immunoconjugates (Immunoconjugate)
IBA
01/2016
1
Protein Isoforms (Isoforms)
IBA
01/2016
1
ruxolitinib
IBA
03/2015
1
Cytarabine (Cytosar-U)
FDA Link
Generic
07/2014
1
Anthracyclines
IBA
07/2014
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2014
1
mocetinostat
IBA
12/2011
1
Prednisone (Sone)
FDA Link
Generic
11/2008
1
Vincristine (Oncovin)
FDA Link
Generic
11/2008
1
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2008
1
Cytokines
IBA
03/2007
1
oblimersen (G3139)
IBA
03/2007
1
Proteins (Proteins, Gene)
FDA Link
03/2007
1
fludarabine
IBA
03/2007
1
Vaccines
IBA
02/2005
1
Proteasome Inhibitors
IBA
02/2005
1
HLA Antigens (Human Leukocyte Antigens)
IBA
09/2003
Therapy/Procedure
11
Therapeutics
04/2024 - 02/2005
7
Drug Therapy (Chemotherapy)
01/2023 - 02/2005
5
Stem Cell Transplantation
01/2023 - 12/2011
4
Hematopoietic Stem Cell Transplantation
07/2015 - 12/2007
2
Radiotherapy
11/2015 - 02/2005
1
Transplantation
01/2023
1
Length of Stay
01/2022
1
Salvage Therapy
01/2020
1
Vena Cava Filters (Inferior Vena Cava Filter)
11/2016
1
Immunotherapy
02/2008
1
Aftercare (After-Treatment)
02/2005